Patrick J Boyle Selected Research

Patrick J Boyle Research Topics

Disease

7	Neoplasms (Cancer) 12/2021 - 01/2004
7	Type 2 Diabetes Mellitus (MODY) 12/2008 - 03/2002
4	Hypoglycemia (Reactive Hypoglycemia) 05/2013 - 01/2006
3	Insulin Resistance 06/2008 - 07/2004
2	Neoplasm Metastasis (Metastasis) 12/2021 - 11/2020
2	Inflammation (Inflammations) 12/2021 - 01/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2008 - 06/2008
2	Atherosclerosis 09/2007 - 07/2004
2	Hyperglycemia 09/2007 - 07/2004
2	Carcinoma (Carcinomatosis) 05/2006 - 01/2004
1	Esophageal Squamous Cell Carcinoma 12/2021
1	Fibrosis (Cirrhosis) 12/2021
1	Foreign Bodies (Foreign Body) 12/2021
1	Diabetes Complications 06/2008
1	Body Weight (Weight, Body) 06/2008
1	Heart Failure 06/2008
1	Atherosclerotic Plaque (Atheroma) 09/2007
1	Dyslipidemias (Dyslipidemia) 09/2007
1	Breast Neoplasms (Breast Cancer) 05/2006
1	Infections 01/2004

Drug/Important Bio-Agent (IBA)

4	LipidsIBA 12/2008 - 03/2002
4	Rosiglitazone (Avandia)FDA Link 12/2008 - 03/2002
4	Pioglitazone (Actos)FDA Link 12/2008 - 03/2002
4	Glucose (Dextrose)FDA LinkGeneric 06/2008 - 01/2006
2	AdiponectinIBA 09/2007 - 07/2004
2	Insulin (Novolin)FDA Link 02/2007 - 01/2006
2	4- propionyloxy- 4- phenyl- N- methylpiperidineIBA 05/2006 - 01/2004
2	2,4-thiazolidinedione (thiazolidinedione)IBA 07/2004 - 01/2004
1	Keratins (Keratin)IBA 12/2021
1	Hormones (Hormone)IBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 06/2008
1	IncretinsIBA 06/2008
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 06/2008
1	Lipoproteins (Lipoprotein)IBA 09/2007
1	Matrix Metalloproteinases (MMPs)IBA 09/2007
1	PPAR-gamma AgonistsIBA 09/2007
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2007
1	Plasminogen Activators (Plasminogen Activator)IBA 09/2007
1	Plasminogen Activator Inhibitor 1IBA 09/2007
1	Hemoglobin AIBA 05/2007
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 05/2007
1	Dipeptidyl-Peptidase IV InhibitorsIBA 05/2007
1	Blood Glucose (Blood Sugar)IBA 02/2007
1	C-Reactive ProteinIBA 01/2007
1	Trypsin InhibitorsIBA 01/2007
1	Serine Proteases (Serine Protease)IBA 01/2007
1	Cytidine Monophosphate (CMP)IBA 05/2006
1	DNA HelicasesIBA 05/2006
1	DNA Polymerase I (Klenow Fragment)IBA 05/2006
1	SialyltransferasesIBA 05/2006
1	GlycosyltransferasesIBA 05/2006
1	GlycosphingolipidsIBA 05/2006
1	GlycolipidsIBA 05/2006
1	Alanine (L-Alanine)FDA Link 01/2006
1	Leucine (L-Leucine)FDA Link 01/2006
1	Oxygen (Dioxygen)IBA 01/2006
1	Adenosine Triphosphate (ATP)IBA 01/2006
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2006
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2004
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2004
1	CytokinesIBA 07/2004
1	Tamoxifen FDA LinkGeneric 01/2004
1	Metformin (Glucophage)FDA LinkGeneric 01/2004
1	GD3 ganglioside (GD(3))IBA 01/2004
1	Melphalan (Alkeran)FDA LinkGeneric 01/2004
1	ImmunosorbentsIBA 01/2004
1	GoldIBA 01/2004
1	GlycoconjugatesIBA 01/2004
1	Caspase 3 (Caspase-3)IBA 01/2004
1	EnzymesIBA 01/2004
1	CeramidesIBA 01/2004
1	Betulinic AcidIBA 01/2004
1	RV 538 (PDMP)IBA 01/2004

Therapy/Procedure

6	Glycemic Control 05/2013 - 03/2002
4	Therapeutics 12/2021 - 01/2004
4	Radiotherapy 12/2021 - 11/2020
2	Drug Therapy (Chemotherapy) 05/2008 - 01/2004
1	Cryosurgery 01/2021
1	Aftercare (After-Treatment) 05/2006